Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2003 2
2005 2
2006 3
2007 3
2008 2
2009 2
2010 4
2011 5
2012 4
2013 10
2014 9
2015 15
2016 2
2017 3
2018 4
2020 3
2021 3
2022 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Results by year

Filters applied: . Clear all
Page 1
Use of genotypic HIV DNA testing: a DELPHI-type consensus.
Andre-Garnier E, Bocket L, Bourlet T, Hocqueloux L, Lepiller Q, Maillard A, Reigadas S, Barriere G, Durand F, Montes B, Stefic K, Marcelin AG. Andre-Garnier E, et al. Among authors: reigadas s. J Antimicrob Chemother. 2024 Mar 1;79(3):578-588. doi: 10.1093/jac/dkae007. J Antimicrob Chemother. 2024. PMID: 38269616 Free PMC article.
Diagnostic Accuracy of Dried Plasma Spot Specimens for HIV-1 Viral Load Testing: A Systematic Review and Meta-analysis.
Fong Y, Markby J, Andreotti M, Beck I, Bourlet T, Brambilla D, Frenkel L, Lira R, Nelson JAE, Pollakis G, Reigadas S, Richman D, Sawadogo S, Waters L, Yang C, Zeh C, Doherty M, Vojnov L. Fong Y, et al. Among authors: reigadas s. J Acquir Immune Defic Syndr. 2022 Mar 1;89(3):261-273. doi: 10.1097/QAI.0000000000002855. J Acquir Immune Defic Syndr. 2022. PMID: 34732684 Free PMC article.
Anti-HIV activity of steric block oligonucleotides.
Ivanova G, Arzumanov AA, Turner JJ, Reigadas S, Toulmé JJ, Brown DE, Lever AM, Gait MJ. Ivanova G, et al. Among authors: reigadas s. Ann N Y Acad Sci. 2006 Oct;1082:103-15. doi: 10.1196/annals.1348.033. Ann N Y Acad Sci. 2006. PMID: 17145931
Virological failure of patients on maraviroc-based antiretroviral therapy.
Raymond S, Maillard A, Amiel C, Peytavin G, Trabaud MA, Desbois D, Bellecave P, Delaugerre C, Soulie C, Marcelin AG, Descamps D, Izopet J; on behalf the ANRS AC11 Resistance Study Group. Raymond S, et al. J Antimicrob Chemother. 2015;70(6):1858-64. doi: 10.1093/jac/dkv026. Epub 2015 Feb 19. J Antimicrob Chemother. 2015. PMID: 25700719
Activation of GCN2 upon HIV-1 infection and inhibition of translation.
Cosnefroy O, Jaspart A, Calmels C, Parissi V, Fleury H, Ventura M, Reigadas S, Andréola ML. Cosnefroy O, et al. Among authors: reigadas s. Cell Mol Life Sci. 2013 Jul;70(13):2411-21. doi: 10.1007/s00018-013-1272-x. Epub 2013 Feb 17. Cell Mol Life Sci. 2013. PMID: 23417324
Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH).
Marcellin F, Di Beo V, Aumaitre H, Mora M, Wittkop L, Duvivier C, Protopopescu C, Lacombe K, Esterle L, Berenger C, Gilbert C, Bouchaud O, Poizot-Martin I, Sogni P, Salmon-Ceron D, Carrieri P; ANRS CO13 HEPAVIH Study Group. Marcellin F, et al. J Hepatol. 2020 Mar;72(3):588-591. doi: 10.1016/j.jhep.2019.10.019. Epub 2020 Jan 7. J Hepatol. 2020. PMID: 31924411 No abstract available.
Emerging resistance mutations in PI-naive patients failing an atazanavir-based regimen (ANRS multicentre observational study).
Lambert-Niclot S, Grude M, Chaix ML, Charpentier C, Reigadas S, Le Guillou-Guillemette H, Rodallec A, Amiel C, Maillard A, Dufayard J, Mourez T, Mirand A, Guinard J, Montes B, Vallet S, Marcelin AG, Descamps D, Flandre P, Delaugerre C, Morand-Joubert L; ANRS AC-11 Resistance Group. Lambert-Niclot S, et al. Among authors: reigadas s. J Antimicrob Chemother. 2018 Aug 1;73(8):2147-2151. doi: 10.1093/jac/dky142. J Antimicrob Chemother. 2018. PMID: 29718247
73 results